The confidence in growth prospects is increasing with the company’s specialty product range in the US shaping up well. Slowdown in sales of global specialty products, witnessed during the lockdown, is also behind for the company. The Street though is keeping a close watch on the competition setting in for its key specialty products. The entry of competition in the arena, however, has already been factored in, say analysts. The company’s chronic portfolio in India has continued to fair well and rebounding acute portfolio growth post lockdown may aid domestic growth.

Source: Mint December 31, 2020 08:25 UTC